Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL). 1983

E O Ukaejiofo, and A S Sagoe, and B O Osunkoya

The surface markers for blood T and B lymphocytes in sixteen consecutively diagnosed patients with CLL were sought for. There were twelve females and four males, and their ages ranged from 30 to 70 years. Although the absolute numbers of T and B lymphocytes were increased, the percentage scores as well as mitogenic responses of these leukaemic cells were depressed, and all the patients except one who has T-cell CLL were considered to have Null-cell CLL. This finding suggests that CLL may take an unusual form in a tropical environment, and this may account for the long remissions which often occur.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008215 Lymphocytes, Null A class of lymphocytes characterized by the lack of surface markers specific for either T or B lymphocytes. Null Cells,Cell, Null,Cells, Null,Lymphocyte, Null,Null Cell,Null Lymphocyte,Null Lymphocytes
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E O Ukaejiofo, and A S Sagoe, and B O Osunkoya
June 1974, British journal of haematology,
E O Ukaejiofo, and A S Sagoe, and B O Osunkoya
May 2003, British journal of haematology,
E O Ukaejiofo, and A S Sagoe, and B O Osunkoya
January 1984, Bollettino dell'Istituto sieroterapico milanese,
E O Ukaejiofo, and A S Sagoe, and B O Osunkoya
April 1979, Journal of clinical & laboratory immunology,
E O Ukaejiofo, and A S Sagoe, and B O Osunkoya
November 1976, Clinical and experimental immunology,
E O Ukaejiofo, and A S Sagoe, and B O Osunkoya
May 1994, Biochemical Society transactions,
E O Ukaejiofo, and A S Sagoe, and B O Osunkoya
January 1989, Bone marrow transplantation,
E O Ukaejiofo, and A S Sagoe, and B O Osunkoya
October 1971, Lancet (London, England),
E O Ukaejiofo, and A S Sagoe, and B O Osunkoya
February 2022, Cells,
E O Ukaejiofo, and A S Sagoe, and B O Osunkoya
February 2016, Current hematologic malignancy reports,
Copied contents to your clipboard!